Navigation Links
By Targeting Specific Germs, Hospital Hopes to Improve Pneumonia Treatment

By analyzing patient characteristics and the particular bacteria causing some patients to develop pneumonia during hospital stays// , Wake Forest University Baptist Medical Center has developed treatment guidelines to more effectively target the germs.

“We matched the best antibiotic combination to each patient’s characteristics and the particular bugs that we have in our hospital,” said James Beardsley, Pharm.D., lead author of the article in this month’s issue of the journal Chest. “We learned that some of the commonly recommended drugs wouldn’t have worked for many of our patients.”

The researchers estimate that antibiotic therapy under the new hospital-specific guidelines will target the correct bacteria in at least 90 percent of cases at risk of being resistant to treatment. If national guidelines were followed, treatment may have correctly targeted the germs in only 70 percent of cases.

Pneumonia is one of the most common hospital-acquired infections. The American Thoracic Society and the Infectious Diseases Society of America joined together to publish national guidelines for treating pneumonia that develops in health care settings, often as a result of patients being on respirators.

Once a patient develops pneumonia, it takes two or three days for laboratory tests to determine exactly what bacteria caused the illness. But treatment must begin right away, so physicians generally use an antibiotic known to be effective against the bacteria that most commonly cause pneumonia. Some patients, especially those who have been in the hospital for several days, are at risk of being infected with bacteria that are resistant to these drugs. This can make it challenging to select the correct antibiotics.

“The choice of which antibiotics to start is very important,” said Beardsley. “They need to cover the germs that are causing the pneumonia in that particular patient. If you’re not right from the start, people ar
'"/>




Page: 1 2

Related medicine news :

1. Novel Technique For Targeting Small-Cell Lung Cancer
2. Targeting PARP1 Is Effective In Protecting HD Cells from Damage
3. Ad Campaign Targeting Republicans On Medicare Prescription Drug Program
4. Highly Potent TB Strain Plays Favorites Targeting Specific Ethnic Groups
5. New Asthma Medicine Targeting Vulnerable Inner-City Children Tested
6. Targeting a Single Gene Could Inhibit Bone Decay and Stimulate Bone Growth
7. Researchers Find Stem-cell Therapy Effective in Targeting Metastatic Cancer
8. Targeting the Adrenal Gland Could Be Key Against Heart Failure
9. Targeting SOCS-3 can Control Obesity
10. Sex Abstinence Programs Targeting School-goers may Not Produce Desired Effect , Study
11. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
Post Your Comments:
(Date:7/25/2008)... DALLAS, July 25 /PRNewswire/ -- BeaconEquity.c...tocks making news today., Investors can view all ...http://BeaconEquity.com/m , Today,s Trade Alerts ...),MiddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK...daq: ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and...
(Date:7/25/2008)... Expanded Relationship Based on Significant Improv...wswire/ -- MDdatacor, Inc., a leader in health,car...d providers, today,announced it has entered into a...ue to support Wellmark,s Collaboration on Quality(... collaboration between Wellmark and,primary care c...
(Date:7/25/2008)... CARLSBAD, Calif., July 25 /PRNewswire/ -- Auto... registration statement on Form S-1 with the,Secur...osed initial public,offering of shares of its comm...be offered, all of which are expected to be offere...he offering, have not yet been,determined., J.P. ...
(Date:7/25/2008)... Whether you are an Olymp...d Warrior, there are Five Things You Need to Know ...the D.I.S.C. Spine and Sports Center , ...25, 2008 -- America,s premier athletes are heading...onditioning and sacrifice in the hopes of capturin...
Breaking Medicine News(10 mins):Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...nge name for something even more surprising - a cu...ent, and its Vietnamese advocates say it ends depe...ays. This happens without side effects and without... with the Methadone treatment). If it is really a ...
...eveals for the first time one of the mechanisms by... skin cancer, grows and spreads. This discovery ma...ll arsenal of treatments available for this danger...ew melanoma treatment target in decades. Study pro...
... initiated by World HealthOrganization's (WHO) aut...le official and unofficialsources, soon after any ...o international publichealth. In a crucial decisio... WHO would carry out a through on-the-spotinvestig...
...t of elderly people over age 85 have Alzheimer’s d...mone therapy may cause some postmenopausal women t...with many cognitive disorders, including Alzheimer...ty studied more than 4,500 postmenopausal women wh...
Other Medicine News:Health News:Hope for First New Melanoma Treatment in Decades 2
(Date:7/24/2008)...FirstCall/ -- MacroChem Corporation (OTC,Bulletin ...clinical trial,involving 37 patients who completed... and safety study of EcoNail, a topical antifungal...fungus). The composite,primary efficacy endpoint o...e mycology (negative fungal culture and negative K...
(Date:7/23/2008)...-- Sound Pharmaceuticals (SPI) has filed,an Invest...e clinical,testing of a proprietary formulation of...d hearing loss or ototoxicity. The oral capsule,co...nced stage lung cancer,and head and neck cancer pa... marks the second development program for SPI to e...
(Date:7/23/2008)...wire/ -- InCode BioPharmaceutics, Inc.,an emergin...inical test,results demonstrating the utility of t...f the rare chronic blood disorder paroxysmal noctu...ll be presented at the XXII,International Compleme...008., The only treatment currently available for ...
(Date:7/22/2008)... a multi-center 293-patient European, trial -, ...Symbol: CYT, MONTREAL, July 22 /PRNewswire-FirstC...eader in cryotherapy products to treat cardiac,arr...presented from three,European study centers using ...published earlier today in the Journal of the Amer...
Breaking Medicine Technology:MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 32008 Social Security Report Offers Dire Warning 15317 12008 Social Security Report Offers Dire Warning 15317 2Core Informatics Completes Successful LIMS Implementation for Progenics Pharmaceuticals 4226 1Cells from the Research Institute of the MUHC on the road to China 15315 1Cells from the Research Institute of the MUHC on the road to China 15315 2Yale study shows weight bias is as prevalent as racial discrimination 15312 1
...lts from analyses,looking at factors contributin...(UC), were presented at Digestive Disease Week,(...by Procter &,Gamble (P&G) Pharmaceuticals, Inc. ... improvement of quality of life for UC,patients ... a class,of agents known as 5-ASAs. A separate s...
...ge of Cardiology,s,Board of Trustees has approved ...arising from his statements that resulted in the,b...rgo on the,COURAGE trial data presented at America...ific Session in March. ,The Board accepted the rec... Committee to issue a letter of censure to and pro...
Other Medicine Technology:Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 2Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 3Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 4Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 5
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: